Are you Marco A. Araneda, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileAt a glance
- 2121 Pease St, Suite 101, Harlingen, TX 78550
About Dr. Araneda
Based in Harlingen, TX, Marco A. Araneda, M.D. is listed in the NPI registry under hematology & oncology. Marco is also listed as specializing in medical oncology. According to Medicare claims data, Marco cared for 1,777 Medicare patients across 58,437 services. The services billed most often include injection, iron sucrose, 1 mg, injection, fosaprepitant, 1 mg, and injection, pembrolizumab, 1 mg. NPI 1336181502 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Education & Training
Specialty
Credentials & Licensing
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (956) 425-8845
- Email not available
Is this your home address or personal number? Hide it
Practice Locations
2121 PEASE ST SUITE 101
Harlingen, TX 78550
Conditions Commonly Evaluated or Treated
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Anemia
- Blood clots
- Breast cancer
- Colon cancer
- Iron-deficiency anemia
- Leukemia
- Lung cancer
- Lymphoma
- Prostate cancer
Advanced Cancers
- Cancer That Has Spread
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
- Bleeding Disorders
- Blood Clot in Lung
- Blood Clotting Gene Mutation
- Deep vein thrombosis
- Hemochromatosis
- High Platelet Count
- High White Blood Cell Count
- Low Platelets
- Low White Blood Cell Count
- Thick Blood
- Unexplained Bruising
Blood disorders
- Bone Marrow Scarring
- Hemolytic Anemia in Children
- Pre-Myeloma Protein In Blood
- Vitamin B12 deficiency anemia
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
- Anal cancer
- Appendix cancer
- Bile duct cancer
- Gallbladder cancer
General oncology
- Cancer of unknown primary
Genetic Blood Disorders
- Sickle cell disease
- Thalassemia
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
- High calcium from cancer
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Procedures & services
Biopsies & Diagnostics
- Bone Marrow Biopsy
- Lumbar puncture
- Lymph Node Biopsy
Cancer care
- Cancer symptom support
Pain & wellness
Most searched procedures
- Blood transfusion
- Chemotherapy
- Immunotherapy
- Targeted therapy
Blood disorder care
- Blood Exchange Transfusion
- Photopheresis
Cancer Therapies
- Hormone Therapy For Cancer
Cancer therapy
- Chemo allergy desensitization
- Oral chemotherapy management
- Radiation oncology consultation
- Spinal chemo injection
Cellular Therapies
- CAR-T Therapy
- Stem Cell Transplant
Consultations
- Cancer Survivorship Care Plan
- Clinical Trial Screening
- Second Opinion For Cancer
Diagnostic testing
- Circulating tumor cell test
Hematology Treatments
- Blood Clot Management
- Plasmapheresis
- PRP Injection
- Therapeutic Blood Draw
Imaging
Infusions
- Clotting Factor Replacement
- Iron Infusion
- IV fluids
- IVIG Infusion
Interventional oncology
- Radiofrequency ablation
- TACE Chemoembolization
Supportive Cancer Care
- Bone Strengthening Injections For Cancer
- Pain Management For Cancer
- Red Blood Cell Booster Shot
- White Blood Cell Booster Injection
Supportive cancer care
- Cancer nutrition counseling
- Chemo brain treatment
- Cold cap therapy for hair loss
- Fertility Preservation for Teens Before Cancer Treatment
- Hyperbaric oxygen for radiation damage
- Lymphedema Drainage Therapy
- Palliative cancer care
Surgical & Vascular Access
- Chemo port placement
- Chemo port removal
- Draining lung fluid
- Paracentesis
- PICC line placement coordination
Testing & Genetics
- Cancer Genetic Testing
- Cancer Tumor Profiling
- Liquid Biopsy
Vascular access care
- Chemo port check
- Chemo Port Flush And Maintenance
- PICC line dressing change
Procedures Most Often Billed to Medicare
58,437 services · 1,777 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
552 | As often as other peers in Hematology & Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Treatment | 96367 |
296 | More often than most peers in Hematology & Oncology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
285 | More often than most peers in Hematology & Oncology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
240 | More often than most peers in Hematology & Oncology |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
182 | More often than most peers in Hematology & Oncology |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
154 | More often than most peers in Hematology & Oncology |
| Injection, iron sucrose, 1 mg | Drug given | J1756 |
17,200 | More often than most peers in Hematology & Oncology |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
10,050 | More often than most peers in Hematology & Oncology |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
8,500 | Less often than most peers in Hematology & Oncology |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Drug given | J0881 |
6,160 | Less often than most peers in Hematology & Oncology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
Other cancer specialists in Harlingen 4
Same specialty, same city.
Trained at Other 8
Other providers in the same specialty who trained at the same institution.
More connections — 15 related providers in 2 groups
Class of 1989 at Other 8
Providers who graduated from the same medical school in the same year.
Also performs Insertion of needle into vein for collection of blood sample 7
Providers in TX who bill this service to Medicare most often.
Common questions
What is Marco A. Araneda's specialty?
Marco A. Araneda is a cancer specialist in Harlingen, TX. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Where can I find Marco A. Araneda?
Marco A. Araneda is listed at 2121 Pease St Suite 101, Harlingen, TX 78550. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
How do I contact Marco A. Araneda?
The number on file is (956) 425-8845. Contact the office directly to confirm availability and scheduling.
NPI registry
What is Marco A. Araneda's NPI number?
Marco A. Araneda's National Provider Identifier is 1336181502. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
What is Marco A. Araneda's education?
Marco A. Araneda attended Other, graduating in 1989. This comes from the CMS National Downloadable File.
CMS public data
How long has Marco A. Araneda been practicing?
Marco A. Araneda has 37 years experience. Calculated from a graduation year of 1989, reported in the CMS National Downloadable File.
CMS public data
What is Marco A. Araneda known for?
According to Medicare billing data, Marco A. Araneda performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Has Marco A. Araneda confirmed this information?
Not yet. This profile is built from public federal data and has not been confirmed by Marco A. Araneda. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.